Timing of Initiation of Methadone Take-Home Dosing: Evidence Synthesis and Clinical Implications for Opioid Use Disorder Management

MedXY Editorial Team•Sep 17, 2026•Anesthesiology

Initiation of take-home methadone dosing within 5 to 24 weeks after OAT induction significantly reduces all-cause mortality and methadone discontinuation compared to no take-home dosing.
Any initiation of take-home dosing, even as early as within 4 weeks, is associated with better outcomes than daily witnessed ingestion without take-home privileges.
COVID-19 pandemic-related regulatory relaxations enhancing take-home dosing led to improved treatment retention and increased enrollment without adversely affecting survival.
Urine drug testing frequency and baseline polysubstance use impact treatment retention, but baseline anxiety does not significantly affect OAT retention, highlighting multifactorial determinants of treatment success.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Initiation of take-home methadone dosing within 5 to 24 weeks after OAT induction significantly reduces all-cause mortality and methadone discontinuation compared to no take-home dosing.
Any initiation of take-home dosing, even as early as within 4 weeks, is associated with better outcomes than daily witnessed ingestion without take-home privileges.
COVID-19 pandemic-related regulatory relaxations enhancing take-home dosing led to improved treatment retention and increased enrollment without adversely affecting survival.
Urine drug testing frequency and baseline polysubstance use impact treatment retention, but baseline anxiety does not significantly affect OAT retention, highlighting multifactorial determinants of treatment success.